Found: 1
Select item for more details and to access through your institution.
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
- Published in:
- 2019
- By:
- Publication type:
- journal article